APOLIFE, INC.

Basic Information

100 RIVER PLACE, SUITE 6800
DETROIT, MI, 48207-

Company Profile

n/a

Additional Details

Field Value
DUNS: 044306905
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. Not Available

    Amount: $297,532.00

    ApoLife is developing yeast platform-Twin Cassette yeast vectors for cost effective manufacturing of antibodies. Using recent collaboration with a company with proprietary S. cerevisiae yeast strains ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. N/A

    Amount: $110,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  3. RECOMBINANT MONOCLONAL ANTIBODIES IN YEAST

    Amount: $100,000.00

    The use of monoclonal antibodies (MABs) in diagnostic and therapeutics applications is on the rise; yet there are limitations to the current hybridoma technology. There is a need to develop less expen ...

    SBIR Phase I 1997 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government